These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6117538)

  • 1. [Pharmacokinetic and biological effective time of beta-receptor blockers in renal insufficiency].
    Knauf H; Schäfer-Korting M; Mutschler E
    Internist (Berl); 1981 Oct; 22(10):616-21. PubMed ID: 6117538
    [No Abstract]   [Full Text] [Related]  

  • 2. [Introduction to the topic: drug dosage in renal insufficiency].
    Sieberth HG
    Internist (Berl); 1981 Oct; 22(10):597-600. PubMed ID: 7028661
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacokinetics of diuretics and antihypertensives in renal insufficiency].
    Kindler J; Schulz V
    Internist (Berl); 1981 Oct; 22(10):607-15. PubMed ID: 7028663
    [No Abstract]   [Full Text] [Related]  

  • 4. [Digitalis glycosides and renal insufficiency].
    Grabensee B; Peters U; Risler T
    Internist (Berl); 1981 Oct; 22(10):622-8. PubMed ID: 7028664
    [No Abstract]   [Full Text] [Related]  

  • 5. [The dosage of important antibiotics and tuberculostatics in renal insufficiency].
    Höffler D
    Internist (Berl); 1981 Oct; 22(10):601-6. PubMed ID: 7028662
    [No Abstract]   [Full Text] [Related]  

  • 6. [When is determination of drug concentrations in plasma useful or necessary?].
    Roots I
    Internist (Berl); 1986 Jan; 27(1):40-52. PubMed ID: 3514516
    [No Abstract]   [Full Text] [Related]  

  • 7. The clinical pharmacology of beta-adrenergic blockers.
    Lowenthal DT
    Cardiovasc Clin; 1984; 14(3):61-71. PubMed ID: 6144391
    [No Abstract]   [Full Text] [Related]  

  • 8. [Altered pharmacokinetics and dosage of antirheumatics, corticosteroids, cytostatics and immunosuppressives in renal insufficiency].
    Vlaho M; Gross R
    Internist (Berl); 1981 Oct; 22(10):629-35. PubMed ID: 7028665
    [No Abstract]   [Full Text] [Related]  

  • 9. [Retention of metabolites of a beta-blocking drug, oxprenolol, in renal insufficiency].
    Dayer P; Glasson P; Gorgia A; Balant L; Fabre J
    Schweiz Med Wochenschr; 1981 Dec; 111(49):1915-8. PubMed ID: 7330645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Butofilolol pharmacokinetics in chronic renal insufficiency.
    Jeanniot JP; Houin G; Ledudal P; Cautreels W; Giudicelli CP; Tillement JP
    Int J Clin Pharmacol Res; 1984; 4(3):165-73. PubMed ID: 6149194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug therapy in renal failure].
    Lachhein L
    Z Gesamte Inn Med; 1980 Aug; 35(15):Suppl 38-40. PubMed ID: 7467564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lipid metabolism and lipid utilization in renal failure].
    Druml W; Laggner A; Lenz K; Balcke P; Kleinberger G; Schmidt P
    Infusionsther Klin Ernahr; 1983 Aug; 10(4):206-12. PubMed ID: 6618660
    [No Abstract]   [Full Text] [Related]  

  • 13. Altered pharmacokinetics of beta-adrenoceptor blocking drugs in patients with renal insufficiency.
    Tjandramaga TB
    Arch Int Pharmacodyn Ther; 1980; Suppl():38-53. PubMed ID: 6106457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consequences of renal insufficiency on the hepatic clearance of some drugs.
    Balant LP; Dayer P; Fabre J
    Int J Clin Pharmacol Res; 1983; 3(6):459-74. PubMed ID: 6147317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digitalis therapy in renal failure with special regard to digitoxin.
    Vöhringer HF; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1981 Apr; 19(4):175-84. PubMed ID: 7021432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug prescribing in children with renal failure.
    Moudgil A; Srivastava RN
    Indian Pediatr; 1989 Jul; 26(7):693-705. PubMed ID: 2684862
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma catecholamine concentration in hypertensive subjects with chronic renal failure before and during treatment with the beta-receptor blocking drug metipranolol.
    Planz G; Haass H; Lamberts B
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):469-73. PubMed ID: 6128312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-adrenergic blockers in systemic hypertension: pharmacokinetic considerations related to the current guidelines.
    Frishman WH; Alwarshetty M
    Clin Pharmacokinet; 2002; 41(7):505-16. PubMed ID: 12083978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Unwanted and toxic drug effects].
    Dominok GW; Terhaag B
    Z Arztl Fortbild (Jena); 1984; 78(23):973-6. PubMed ID: 6528640
    [No Abstract]   [Full Text] [Related]  

  • 20. [High plasma concentrations of calcitonin in acute and chronic renal insufficiency].
    Ardaillou R; Isaac R; Beaufils M; Nivez MP
    J Urol Nephrol (Paris); 1976; 82(4-5):371. PubMed ID: 940185
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.